Blogroll

At least 15 states are investigating cases of a rare inflammatory syndrome impacting children that is believed to be linked to the novel coronavirus, New York Governor Andrew Cuomo said on Wednesday.

Shares in AMS fell by 11% on Wednesday following news the sensor maker, best known as a supplier to Apple , was seeking approval for a capital raise.

The following is a brief roundup of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

On a doorstep in the suburbs of north London, three-year-old Ayse picked up a tissue to wipe away her grandmother's tears - tears for one more victim of the virus.

Campaigners for the welfare of elderly people and their relatives are calling on the UK government to be more transparent after authorities declined to disclose the number of COVID-19 deaths in individual care homes.

Preliminary results from a nationwide coronavirus antibody study show that about 5% of the overall Spanish population has been affected, the Health Ministry said on Wednesday, adding that results varied widely from region to region.

Social networks and other online content providers will have to remove paedophile and terrorism-related content from their platforms within the hour or face a fine of up to 4% of their global revenue under a French law voted in on Wednesday.

Israel gave approval on Wednesday for exports of medical cannabis, paving the way for sales abroad that the government expects to produce hundreds of millions of dollars in revenue.

The world has a "long, long way to go" to bring the coronavirus pandemic under control, despite tentative steps in many countries to begin restarting normal life, the World Health Organization's top emergencies expert warned on Wednesday.

Communist-run Cuba, laboring under a six-decade U.S. embargo, is betting a biotech sector begun by late revolutionary leader Fidel Castro can give the Caribbean island an edge in a global race to find effective treatments for the new coronavirus.

U.S. President Donald Trump on Wednesday extended for another year an executive order signed in May 2019 declaring a national emergency and barring U.S. companies from using telecommunications equipment made by firms posing a national security risk.

Love led a young Swiss doctor to emigrate to South Africa, his wife's home country. Years later, love for his disabled child brought him back to Switzerland.

Deaths from the COVID-19 epidemic in Italy climbed by 195 on Wednesday, against 172 the day before, the Civil Protection Agency said, but the daily tally of new cases fell to 888 from 1,402 on Tuesday.

Italian diagnostics group DiaSorin received on Tuesday approval from Canadian authorities to sell its COVID-19 antibody tests but will not supply its testing kits to the Italian government, Chief Executive Carlo Rosa said on Wednesday.

U.S. health officials said on Wednesday they will issue an alert telling doctors to report cases of a rare life-threatening inflammatory syndrome associated with COVID-19 in children to their state and local health departments.

Bristol Myers Squibb Co said on Wednesday it planned to resubmit its application for an experimental multiple myeloma therapy by the end of July after the U.S. drug regulator declined to review the treatment as it sought more information.

The World Health Organization said on Tuesday that some treatments appear to be limiting the severity or length of the COVID-19 disease, referring to the results of early studies of four or five treatments.

A candidate drug for treating the new coronavirus, favipiravir, has produced promising results in early clinical trials in Russia, according to the Russian Direct Investment Fund, which provided 150 million roubles ($2 million) in funding for the project.

As the spread of the new coronavirus in Canada slows, the western province of Alberta has rolled out a digital-tracing tool to monitor outbreaks as quarantine restrictions ease. The hard part is convincing people to use it.

(This May 12 story corrects Chinese name of lab to Huo-Yan, not Huo-Yun)